Today is August 19, 2024.
All times in Eastern Daylight Time.
-
Amylyx Pharmaceuticals Receives Orphan Drug Designation From the European Commission for AMX0035 for the Treatment of Wolfram Syndrome
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals Receives Orphan Drug Designation from the European Commission for AMX0035 for the Treatment of Wolfram Syndrome more »
-
OS Therapies Forms Osteosarcoma Patient Advocacy Advisory Board
ROCKVILLE, Md. & NEW YORK--(BUSINESS WIRE)--OS Therapies Incorporated (“OS Therapies” or the “Company”) (NYSE-A: OSTX), a Cancer Immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical co... more »
-
Enfusion Introduces the Next Phase of Portfolio Workbench, Empowering Asset Managers with Increased Efficiency and Flexibility
NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, announced today the r... more »
-
Watson Farley & Williams and DISCO Expand Strategic Ediscovery Partnership
AUSTIN, Texas--(BUSINESS WIRE)--DISCO (NYSE: LAW), a leader in AI-enabled legal technology, announced it has been selected by Watson Farley & Williams (WFW), a prominent Global 200 law firm, as... more »
-
Ambac Completes Acquisition of Beat Capital Partners
NEW YORK--(BUSINESS WIRE)--Ambac completes acquisition of Beat Capital Partners more »
-
Alcoa Issues 2023 Sustainability Report
PITTSBURGH--(BUSINESS WIRE)--Alcoa Corporation releases 2023 Sustainability Report. more »
-
Amlogenyx Inc. Closes Successful Seed Funding Led by GordonMD® Global Investments LP
BEVERLY HILLS, Calif.--(BUSINESS WIRE)--GordonMD® Global Investments LP announced today that Amlogenyx Inc. has completed a seed funding round of USD 14 million. Amlogenyx, a subsidiary of Ultragen... more »
-
Coya Therapeutics Announces that Results from a Double-Blind Placebo-Controlled Study in Alzheimer’s Disease will be presented on October 29, 2024 at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) in Madrid
HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) ... more »
-
The ONE Group Hospitality, Inc. to Host Second Quarter 2024 Earnings Conference Call and Webcast at 4:30 PM ET on August 6, 2024
DENVER--(BUSINESS WIRE)--The ONE Group Hospitality, Inc. (“The ONE Group” or the “Company”) (Nasdaq: STKS) today announced that Emanuel “Manny” Hilario, President and Chief Executive Officer, and T... more »
-
Western Asset Investment Grade Defined Opportunity Trust Inc. Announces Tender Offer Details
NEW YORK--(BUSINESS WIRE)--Category: Fund Announcement more »
-
Western Asset Global Corporate Defined Opportunity Fund Inc. Announces Tender Offer Details
NEW YORK--(BUSINESS WIRE)--Category: Fund Announcement more »
-
OFS Credit Company Increases Monthly Common Stock Distributions
CHICAGO--(BUSINESS WIRE)--OFS Credit Company, Inc. (NASDAQ: OCCI) (“OFS Credit,” the “Company,” “we,” “us” or “our”), an investment company that primarily invests in collateralized loan obligation ... more »
-
Olo to Present at the KeyBanc Technology Leadership Forum
NEW YORK--(BUSINESS WIRE)--Olo Inc. (NYSE:OLO), a leading open SaaS platform for restaurants, today announced that Peter Benevides, CFO, will present at the KeyBanc Technology Leadership Forum in V... more »
-
Moog Inc. Announces Cash Dividend
EAST AURORA, N.Y.--(BUSINESS WIRE)--Moog Inc. Announces Cash Dividend more »
-
Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today annou... more »
-
Newsmax Announces Planned Public Offering, Private Offering Investor Webinar
BOCA RATON, Fla.--(BUSINESS WIRE)--Newsmax Inc. (“Newsmax” or the “Company”) is pleased to announce it will host an online Special Investor Webinar conversation with its CEO, Christopher Ruddy, on ... more »
-
Franklin Templeton Fund Adviser, LLC Announces Distributions for the Month of August 2024
NEW YORK--(BUSINESS WIRE)--Category: Distribution Related more »
-
Marcus & Millichap Declares Regular Semi-Annual Dividend of $0.25 Per Share
CALABASAS, Calif.--(BUSINESS WIRE)--Marcus & Millichap Inc. (NYSE: MMI), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory servi... more »
-
Agilent Receives FDA Approval for MAGE-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc., (NYSE: A) today announced that it has received FDA approval for the use of MAGE-A4 IHC 1F9 pharmDx (SK032) as a diagnostic tool to a... more »
-
Imperial announces second quarter 2024 financial and operating results
CALGARY, Alberta--(BUSINESS WIRE)--Imperial (TSE: IMO) (NYSE American: IMO): Second quarter Six months millions of Canadian dollars, unless noted 2024 2023 ∆ 2024 2023 ∆ Net income (loss) (U.S. G... more »
-
Moog Inc. Reports Strong Third Quarter 2024 Results with Further Margin Expansion
EAST AURORA, N.Y.--(BUSINESS WIRE)--Moog Inc. Reports Strong Third Quarter 2024 Results with Further Margin Expansion more »
-
Imperial declares third quarter 2024 dividend
CALGARY, Alberta--(BUSINESS WIRE)--Imperial Oil Limited (TSE: IMO, NYSE American: IMO) today declared a quarterly dividend of 60 cents per share on the outstanding common shares of the company, pay... more »
-
DocGo Secures $4 Million Contract Extension to Continue Vital 911 Basic Life Support Services for Atlantic City, New Jersey
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that Exceptional Medical Transporta... more »
-
Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silic... more »
-
Allego N.V. Announces Voluntarily Delisting from the New York Stock Exchange
PARIS & ARNHEM, Netherlands--(BUSINESS WIRE)--Allego N.V. (“Allego” or the “Company”) (NYSE: ALLG), a leading provider of electric vehicle charging solutions, today announced that it has commenced ... more »
|
|